SANOFI (SNW.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:SNW • FR0000120578

81.71 EUR
+0.99 (+1.23%)
Last: Feb 4, 2026, 07:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to SNW. SNW was compared to 55 industry peers in the Pharmaceuticals industry. SNW has a medium profitability rating, but doesn't score so well on its financial health evaluation. SNW has a decent growth rate and is not valued too expensively. Finally SNW also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • SNW had positive earnings in the past year.
  • In the past 5 years SNW has always been profitable.
  • SNW had a positive operating cash flow in each of the past 5 years.
SNW.DE Yearly Net Income VS EBIT VS OCF VS FCFSNW.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • SNW has a Return On Assets of 10.63%. This is in the better half of the industry: SNW outperforms 76.36% of its industry peers.
  • SNW has a better Return On Equity (18.84%) than 61.82% of its industry peers.
  • SNW's Return On Invested Capital of 13.35% is fine compared to the rest of the industry. SNW outperforms 65.45% of its industry peers.
  • SNW had an Average Return On Invested Capital over the past 3 years of 7.41%. This is significantly below the industry average of 14.23%.
  • The 3 year average ROIC (7.41%) for SNW is below the current ROIC(13.35%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROIC 13.35%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
SNW.DE Yearly ROA, ROE, ROICSNW.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • SNW has a better Profit Margin (20.63%) than 80.00% of its industry peers.
  • SNW's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 23.61%, SNW is in line with its industry, outperforming 56.36% of the companies in the same industry.
  • In the last couple of years the Operating Margin of SNW has grown nicely.
  • SNW has a Gross Margin (72.29%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of SNW has remained more or less at the same level.
Industry RankSector Rank
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
SNW.DE Yearly Profit, Operating, Gross MarginsSNW.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

  • SNW has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for SNW has been reduced compared to 1 year ago.
  • Compared to 5 years ago, SNW has less shares outstanding
  • Compared to 1 year ago, SNW has a worse debt to assets ratio.
SNW.DE Yearly Shares OutstandingSNW.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
SNW.DE Yearly Total Debt VS Total AssetsSNW.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • A Debt/Equity ratio of 0.18 indicates that SNW is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.18, SNW is in the better half of the industry, outperforming 78.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC1.71
WACC7.8%
SNW.DE Yearly LT Debt VS Equity VS FCFSNW.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • SNW has a Current Ratio of 1.06. This is a normal value and indicates that SNW is financially healthy and should not expect problems in meeting its short term obligations.
  • SNW's Current ratio of 1.06 is on the low side compared to the rest of the industry. SNW is outperformed by 72.73% of its industry peers.
  • A Quick Ratio of 0.30 indicates that SNW may have some problems paying its short term obligations.
  • The Quick ratio of SNW (0.30) is worse than 89.09% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.3
SNW.DE Yearly Current Assets VS Current LiabilitesSNW.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

4

3. Growth

3.1 Past

  • The earnings per share for SNW have decreased by -8.39% in the last year.
  • Measured over the past 5 years, SNW shows a small growth in Earnings Per Share. The EPS has been growing by 3.37% on average per year.
  • Looking at the last year, SNW shows a small growth in Revenue. The Revenue has grown by 5.49% in the last year.
  • SNW shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.57% yearly.
EPS 1Y (TTM)-8.39%
EPS 3Y-5.17%
EPS 5Y3.37%
EPS Q2Q%-43.11%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%4.2%

3.2 Future

  • Based on estimates for the next years, SNW will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.19% on average per year.
  • Based on estimates for the next years, SNW will show a small growth in Revenue. The Revenue will grow by 5.52% on average per year.
EPS Next Y20.15%
EPS Next 2Y12.73%
EPS Next 3Y12.69%
EPS Next 5Y11.19%
Revenue Next Year6.49%
Revenue Next 2Y6.66%
Revenue Next 3Y5.93%
Revenue Next 5Y5.52%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SNW.DE Yearly Revenue VS EstimatesSNW.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
SNW.DE Yearly EPS VS EstimatesSNW.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 11.61, the valuation of SNW can be described as reasonable.
  • Based on the Price/Earnings ratio, SNW is valued cheaply inside the industry as 85.45% of the companies are valued more expensively.
  • SNW's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.25.
  • A Price/Forward Earnings ratio of 9.67 indicates a reasonable valuation of SNW.
  • SNW's Price/Forward Earnings ratio is rather cheap when compared to the industry. SNW is cheaper than 85.45% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of SNW to the average of the S&P500 Index (27.50), we can say SNW is valued rather cheaply.
Industry RankSector Rank
PE 11.61
Fwd PE 9.67
SNW.DE Price Earnings VS Forward Price EarningsSNW.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SNW.DE Per share dataSNW.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of SNW may justify a higher PE ratio.
  • A more expensive valuation may be justified as SNW's earnings are expected to grow with 12.69% in the coming years.
PEG (NY)0.58
PEG (5Y)3.44
EPS Next 2Y12.73%
EPS Next 3Y12.69%

More info and screens

8

5. Dividend

5.1 Amount

  • SNW has a Yearly Dividend Yield of 5.35%, which is a nice return.
  • Compared to an average industry Dividend Yield of 1.95, SNW pays a better dividend. On top of this SNW pays more dividend than 94.55% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, SNW pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.35%

5.2 History

  • The dividend of SNW has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
SNW.DE Yearly Dividends per shareSNW.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • SNW pays out 34.36% of its income as dividend. This is a sustainable payout ratio.
  • SNW's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.36%
EPS Next 2Y12.73%
EPS Next 3Y12.69%
SNW.DE Yearly Income VS Free CF VS DividendSNW.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
SNW.DE Dividend Payout.SNW.DE Dividend Payout, showing the Payout Ratio.SNW.DE Dividend Payout.PayoutRetained Earnings

More info and screens

SANOFI

FRA:SNW (2/4/2026, 7:00:00 PM)

81.71

+0.99 (+1.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners46.74%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap197.35B
Revenue(TTM)46.72B
Net Income(TTM)13.80B
Analysts79.31
Price Target101.29 (23.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.35%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.36%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.79%
Min EPS beat(2)-2.29%
Max EPS beat(2)5.86%
EPS beat(4)2
Avg EPS beat(4)1.85%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)5
Avg EPS beat(8)3.19%
EPS beat(12)7
Avg EPS beat(12)2.67%
EPS beat(16)11
Avg EPS beat(16)3.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.95%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)4
Avg Revenue beat(12)9.01%
Revenue beat(16)8
Avg Revenue beat(16)21.12%
PT rev (1m)-4.86%
PT rev (3m)-7.55%
EPS NQ rev (1m)2.75%
EPS NQ rev (3m)-7.26%
EPS NY rev (1m)-0.59%
EPS NY rev (3m)-2.58%
Revenue NQ rev (1m)0.41%
Revenue NQ rev (3m)0.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.16%
Valuation
Industry RankSector Rank
PE 11.61
Fwd PE 9.67
P/S 2.95
P/FCF N/A
P/OCF N/A
P/B 2.69
P/tB 44.89
EV/EBITDA N/A
EPS(TTM)7.04
EY8.62%
EPS(NY)8.45
Fwd EY10.35%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS27.7
BVpS30.33
TBVpS1.82
PEG (NY)0.58
PEG (5Y)3.44
Graham Number69.32
Profitability
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROCE 16.17%
ROIC 13.35%
ROICexc 14.69%
ROICexgc 65.49%
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
FCFM N/A
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
ROICexc(3y)8.06%
ROICexc(5y)8.26%
ROICexgc(3y)31.82%
ROICexgc(5y)35.77%
ROCE(3y)8.99%
ROCE(5y)9.04%
ROICexgc growth 3Y-8.07%
ROICexgc growth 5Y1.04%
ROICexc growth 3Y-0.36%
ROICexc growth 5Y3.93%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
F-ScoreN/A
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.3
Altman-Z N/A
F-ScoreN/A
WACC7.8%
ROIC/WACC1.71
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)127.25%
Profit Quality(5y)123.49%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.39%
EPS 3Y-5.17%
EPS 5Y3.37%
EPS Q2Q%-43.11%
EPS Next Y20.15%
EPS Next 2Y12.73%
EPS Next 3Y12.69%
EPS Next 5Y11.19%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%4.2%
Revenue Next Year6.49%
Revenue Next 2Y6.66%
Revenue Next 3Y5.93%
Revenue Next 5Y5.52%
EBIT growth 1Y9.12%
EBIT growth 3Y0.11%
EBIT growth 5Y6.43%
EBIT Next Year28.46%
EBIT Next 3Y13.63%
EBIT Next 5Y10.94%
FCF growth 1Y85.47%
FCF growth 3Y9.46%
FCF growth 5Y15.4%
OCF growth 1Y20.22%
OCF growth 3Y1.22%
OCF growth 5Y8.03%

SANOFI / SNW.DE FAQ

Can you provide the ChartMill fundamental rating for SANOFI?

ChartMill assigns a fundamental rating of 5 / 10 to SNW.DE.


What is the valuation status of SANOFI (SNW.DE) stock?

ChartMill assigns a valuation rating of 6 / 10 to SANOFI (SNW.DE). This can be considered as Fairly Valued.


How profitable is SANOFI (SNW.DE) stock?

SANOFI (SNW.DE) has a profitability rating of 6 / 10.


Can you provide the financial health for SNW stock?

The financial health rating of SANOFI (SNW.DE) is 3 / 10.


What is the earnings growth outlook for SANOFI?

The Earnings per Share (EPS) of SANOFI (SNW.DE) is expected to grow by 20.15% in the next year.